Of the 64,124 cases reported to the Commission in fiscal year 2023, 19,066 involved drugs.[1] Of those, 18,939 cases involved drug trafficking;[2] 1.2% of such cases involved oxycodone (down 46.4% since FY 2019). [3]
Click the cover for the PDF handout or learn more below.
Individual and Offense Characteristics
- 76.9% of individuals sentenced for oxycodone trafficking were men.
- 36.8% were Black, 34.1% were White, 15.5% were Hispanic, and 13.6% were Other races.
- Their average age was 45 years.
- 98.2% were United States citizens.
- 61.1% had little or no prior criminal history (Criminal History Category I); 1.8% were individuals sentenced under the career offender guideline (§4B1.1).
- The median base offense level in these cases was 26, corresponding to between 1,990 and 3,483 30-milligram instant release pills of oxycodone.
- Sentences were increased for:
- possessing a weapon (16.7%);
- a leadership or supervisory role in the offense (14.5%).
- Sentences were decreased for:
- minor or minimal participation in the offense (6.3%);
- meeting the safety valve criteria in the sentencing guidelines (31.2%).
- The top five districts for oxycodone trafficking offenses were:
- District of North Dakota (44);
- Southern District of Florida (14);
- Southern District of Texas (13);
- Southern District of New York (12);
- District of New Jersey (12).
Punishment
- The average sentence for oxycodone trafficking was 52 months.
- 88.7% were sentenced to prison.
- Oxycodone trafficking does not carry a mandatory minimum penalty.
Sentences Relative to the Guideline Range
- Of the 55.2% of individuals sentenced for oxycodone trafficking under the Guidelines Manual:
- 38.5% were sentenced within the guideline range.
- 57.4% received a substantial assistance departure.
- Their average sentence reduction was 70.3%.
- Their average sentence reduction was 70.3%.
- 0.0% received an Early Disposition Program (EDP) departure.[4]
- 3.3% received some other downward departure.
- Their average sentence reduction was 54.6%.
- Their average sentence reduction was 54.6%.
- 38.5% were sentenced within the guideline range.
- 44.8% received a variance; of those individuals:
- 96.0% received a downward variance.
- Their average sentence reduction was 54.2%.
- Their average sentence reduction was 54.2%.
- 4.0% received an upward variance.
- Their average sentence increase was 100.2%.
- 96.0% received a downward variance.
- The average guideline minimum increased and average sentence imposed has fluctuated over the past five years.
- The average guideline minimum increased from 68 months in fiscal year 2019 to 90 months in fiscal year 2023.
- The average sentence imposed increased and decreased throughout the fiscal years. The average sentence was 45 months in fiscal year 2019 and 52 months in fiscal year 2023.
- The average guideline minimum increased from 68 months in fiscal year 2019 to 90 months in fiscal year 2023.
[1] Drug offenses include cases where individuals were sentenced under USSG Chapter Two, Part D (Drugs). There were 234 individuals sentenced for oxycodone offenses sentenced under USSG Chapter Two, Part D (Drugs) in FY 2023.
[2] Individuals sentenced for drug trafficking were sentenced under USSG §§2D1.1 (Drug Trafficking), 2D1.2 (Protected Locations), 2D1.5 (Continuing Criminal Enterprise), 2D1.6 (Use of a Communication Facility), 2D1.8 (Rent/Manage Drug Establishment), 2D1.10 (Endangering Human Life), or 2D1.14 (Narco-Terrorism).
[3] Cases with incomplete sentencing information were excluded from the analysis.
[4] “Early Disposition Program (or EDP) departures” are departures where the government sought a sentence below the guideline range because the defendant participated in the government’s Early Disposition Program, through which cases are resolved in an expedited manner. See USSG §5K3.1.
SOURCE: United States Sentencing Commission, FY 2019 through FY 2023 Datafiles, USSCFY19-USSCFY23.